Ledger.Open graph →
SEC Form D · filed February 16, 2016

KPI Therapeutics, Inc

Offering
$7.5M
Sold
$51K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Don L. Merlino · Seattle, WADirectorJames G. W. L. Reed · Seattle, WADirectorCraig L. Philips · Seattle, WAExecCharles L. Magness · Seattle, WAExec · DirectorPaul L. Sylvester · Seattle, WADirectorBlake L. Ilstrup · Seattle, WAExecDon L. Merlino · Seattle, WADirectorJames G. W. L. Reed · Seattle, WADirectorCraig L. Philips · Seattle, WAExecBlake L. Ilstrup · Seattle, WAExecCharles L. Magness · Seattle, WAExec · DirectorPaul L. Sylvester · Seattle, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗